Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1969 1
1971 1
1972 2
1974 2
1976 3
1977 2
1979 1
1980 1
1981 4
1982 1
1983 9
1984 3
1985 1
1986 1
1987 5
1988 7
1989 1
1990 3
1991 2
1992 2
1993 2
1994 2
1995 4
1996 2
1997 5
1998 2
1999 3
2000 5
2001 1
2002 3
2003 4
2004 8
2005 10
2006 14
2007 9
2008 11
2009 12
2010 15
2011 14
2012 13
2013 9
2014 12
2015 8
2016 12
2017 15
2018 20
2019 22
2020 20
2021 13
2022 12
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

314 results

Results by year

Filters applied: . Clear all
Page 1
Impact of Clinical Characteristics and Biomarkers on AIRQ Exacerbation Prediction Ability.
Murphy KR, Beuther DA, Chipps B, Wise RA, McCann W, Reibman J, George M, Gilbert I, Eudicone JM, Gandhi HN, Ross M, Coyne KS, Zeiger RS. Murphy KR, et al. Among authors: zeiger rs. J Allergy Clin Immunol Pract. 2024 May 3:S2213-2198(24)00436-7. doi: 10.1016/j.jaip.2024.04.050. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 38705273
Advancing assessment of asthma control with a composite tool: The Asthma Impairment and Risk Questionnaire.
Chipps BE, Zeiger RS, Beuther DA, Wise RA, McCann W, Reibman J, George M, Gilbert I, Eudicone JM, Coyne KS, Harding G, Murphy KR. Chipps BE, et al. Among authors: zeiger rs. Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00153-4. doi: 10.1016/j.anai.2024.03.011. Online ahead of print. Ann Allergy Asthma Immunol. 2024. PMID: 38494113 Free article.
Assessing meaningful change in the Asthma Impairment and Risk Questionnaire.
McCann W, Murphy KR, Zeiger RS, Beuther DA, Wise RA, Reibman J, George M, Gilbert I, Eudicone JM, Gandhi HN, Cutts K, Coyne KS, Chipps B. McCann W, et al. Among authors: zeiger rs. Ann Allergy Asthma Immunol. 2024 Feb 17:S1081-1206(24)00085-1. doi: 10.1016/j.anai.2024.02.013. Online ahead of print. Ann Allergy Asthma Immunol. 2024. PMID: 38369256 Free article.
Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study.
Fiocchi AG, Phipatanakul W, Zeiger RS, Durrani SR, Cole J, Msihid J, Gall R, Jacob-Nara JA, Deniz Y, Rowe PJ, Lederer DJ, Hardin M, Zhang Y, Khan AH. Fiocchi AG, et al. Among authors: zeiger rs. Eur Respir J. 2023 Nov 2;62(5):2300558. doi: 10.1183/13993003.00558-2023. Print 2023 Nov. Eur Respir J. 2023. PMID: 37734856 Free PMC article. Clinical Trial.
Confirmatory cross-sectional validation of the Asthma Impairment and Risk Questionnaire.
Wise RA, Chipps B, Murphy KR, Beuther DA, Reibman J, McCann W, Gilbert I, Eudicone JM, Gandhi HN, Harding G, Cutts K, George M, Zeiger RS. Wise RA, et al. Among authors: zeiger rs. J Allergy Clin Immunol Pract. 2023 Nov;11(11):3531-3533.e1. doi: 10.1016/j.jaip.2023.07.018. Epub 2023 Jul 19. J Allergy Clin Immunol Pract. 2023. PMID: 37474101 Free article. No abstract available.
314 results